Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 25 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 2 |
GO:0010494 | cytoplasmic stress granule | 5 | 2 |
GO:0016281 | eukaryotic translation initiation factor 4F complex | 2 | 2 |
GO:0032991 | protein-containing complex | 1 | 2 |
GO:0035770 | ribonucleoprotein granule | 3 | 2 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 4 | 2 |
GO:0043226 | organelle | 2 | 2 |
GO:0043228 | non-membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 2 |
GO:0099080 | supramolecular complex | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: Q4Q813
Term | Name | Level | Count |
---|---|---|---|
GO:0006413 | translational initiation | 3 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0044237 | cellular metabolic process | 2 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000339 | RNA cap binding | 5 | 2 |
GO:0000340 | RNA 7-methylguanosine cap binding | 6 | 2 |
GO:0003676 | nucleic acid binding | 3 | 10 |
GO:0003723 | RNA binding | 4 | 10 |
GO:0003743 | translation initiation factor activity | 4 | 10 |
GO:0005488 | binding | 1 | 10 |
GO:0008135 | translation factor activity, RNA binding | 3 | 10 |
GO:0045182 | translation regulator activity | 1 | 10 |
GO:0090079 | translation regulator activity, nucleic acid binding | 2 | 10 |
GO:0097159 | organic cyclic compound binding | 2 | 10 |
GO:1901363 | heterocyclic compound binding | 2 | 10 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 84 | 88 | PF00656 | 0.755 |
CLV_NRD_NRD_1 | 208 | 210 | PF00675 | 0.325 |
CLV_PCSK_SKI1_1 | 210 | 214 | PF00082 | 0.364 |
CLV_PCSK_SKI1_1 | 242 | 246 | PF00082 | 0.376 |
CLV_PCSK_SKI1_1 | 279 | 283 | PF00082 | 0.375 |
DEG_APCC_DBOX_1 | 302 | 310 | PF00400 | 0.524 |
DEG_MDM2_SWIB_1 | 186 | 193 | PF02201 | 0.524 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.707 |
DEG_SPOP_SBC_1 | 19 | 23 | PF00917 | 0.765 |
DOC_MAPK_gen_1 | 220 | 229 | PF00069 | 0.524 |
DOC_MAPK_gen_1 | 274 | 283 | PF00069 | 0.516 |
DOC_MAPK_HePTP_8 | 273 | 285 | PF00069 | 0.595 |
DOC_MAPK_JIP1_4 | 279 | 285 | PF00069 | 0.564 |
DOC_MAPK_MEF2A_6 | 222 | 231 | PF00069 | 0.541 |
DOC_MAPK_MEF2A_6 | 276 | 285 | PF00069 | 0.578 |
DOC_PP2B_LxvP_1 | 193 | 196 | PF13499 | 0.507 |
DOC_USP7_MATH_1 | 10 | 14 | PF00917 | 0.714 |
DOC_USP7_MATH_1 | 136 | 140 | PF00917 | 0.677 |
DOC_USP7_MATH_1 | 161 | 165 | PF00917 | 0.624 |
DOC_USP7_MATH_1 | 19 | 23 | PF00917 | 0.729 |
DOC_USP7_MATH_1 | 194 | 198 | PF00917 | 0.624 |
DOC_USP7_MATH_1 | 329 | 333 | PF00917 | 0.715 |
DOC_USP7_MATH_1 | 81 | 85 | PF00917 | 0.827 |
DOC_USP7_UBL2_3 | 16 | 20 | PF12436 | 0.791 |
DOC_USP7_UBL2_3 | 313 | 317 | PF12436 | 0.524 |
DOC_USP7_UBL2_3 | 338 | 342 | PF12436 | 0.753 |
DOC_WW_Pin1_4 | 162 | 167 | PF00397 | 0.548 |
DOC_WW_Pin1_4 | 341 | 346 | PF00397 | 0.562 |
LIG_14-3-3_CanoR_1 | 236 | 245 | PF00244 | 0.600 |
LIG_BIR_III_4 | 14 | 18 | PF00653 | 0.762 |
LIG_deltaCOP1_diTrp_1 | 184 | 190 | PF00928 | 0.524 |
LIG_FHA_1 | 224 | 230 | PF00498 | 0.511 |
LIG_FHA_1 | 280 | 286 | PF00498 | 0.556 |
LIG_FHA_1 | 328 | 334 | PF00498 | 0.659 |
LIG_FHA_1 | 71 | 77 | PF00498 | 0.685 |
LIG_FHA_2 | 57 | 63 | PF00498 | 0.780 |
LIG_FHA_2 | 64 | 70 | PF00498 | 0.688 |
LIG_LIR_Apic_2 | 215 | 219 | PF02991 | 0.595 |
LIG_LIR_Gen_1 | 204 | 212 | PF02991 | 0.511 |
LIG_LIR_Gen_1 | 246 | 257 | PF02991 | 0.541 |
LIG_LIR_Nem_3 | 146 | 150 | PF02991 | 0.528 |
LIG_LIR_Nem_3 | 169 | 175 | PF02991 | 0.571 |
LIG_LIR_Nem_3 | 184 | 189 | PF02991 | 0.455 |
LIG_LIR_Nem_3 | 204 | 208 | PF02991 | 0.525 |
LIG_PAM2_1 | 37 | 49 | PF00658 | 0.695 |
LIG_Pex14_2 | 172 | 176 | PF04695 | 0.595 |
LIG_Pex14_2 | 186 | 190 | PF04695 | 0.521 |
LIG_SH2_SRC | 192 | 195 | PF00017 | 0.525 |
LIG_SH2_STAP1 | 203 | 207 | PF00017 | 0.624 |
LIG_SH2_STAT3 | 8 | 11 | PF00017 | 0.719 |
LIG_SH2_STAT5 | 192 | 195 | PF00017 | 0.541 |
LIG_SH2_STAT5 | 203 | 206 | PF00017 | 0.541 |
LIG_SH2_STAT5 | 8 | 11 | PF00017 | 0.758 |
LIG_SH3_3 | 24 | 30 | PF00018 | 0.804 |
LIG_SH3_3 | 42 | 48 | PF00018 | 0.688 |
LIG_SUMO_SIM_anti_2 | 226 | 231 | PF11976 | 0.564 |
LIG_SxIP_EBH_1 | 135 | 147 | PF03271 | 0.648 |
LIG_WRC_WIRS_1 | 183 | 188 | PF05994 | 0.624 |
MOD_CK1_1 | 162 | 168 | PF00069 | 0.601 |
MOD_CK1_1 | 237 | 243 | PF00069 | 0.583 |
MOD_CK1_1 | 55 | 61 | PF00069 | 0.810 |
MOD_CK2_1 | 257 | 263 | PF00069 | 0.524 |
MOD_CK2_1 | 64 | 70 | PF00069 | 0.673 |
MOD_CMANNOS | 187 | 190 | PF00535 | 0.324 |
MOD_GlcNHglycan | 138 | 141 | PF01048 | 0.660 |
MOD_GlcNHglycan | 196 | 199 | PF01048 | 0.364 |
MOD_GlcNHglycan | 22 | 25 | PF01048 | 0.791 |
MOD_GlcNHglycan | 235 | 239 | PF01048 | 0.395 |
MOD_GlcNHglycan | 3 | 6 | PF01048 | 0.765 |
MOD_GlcNHglycan | 39 | 42 | PF01048 | 0.714 |
MOD_GlcNHglycan | 54 | 57 | PF01048 | 0.719 |
MOD_GlcNHglycan | 87 | 90 | PF01048 | 0.826 |
MOD_GSK3_1 | 155 | 162 | PF00069 | 0.596 |
MOD_GSK3_1 | 164 | 171 | PF00069 | 0.598 |
MOD_GSK3_1 | 194 | 201 | PF00069 | 0.564 |
MOD_GSK3_1 | 298 | 305 | PF00069 | 0.576 |
MOD_GSK3_1 | 30 | 37 | PF00069 | 0.736 |
MOD_GSK3_1 | 341 | 348 | PF00069 | 0.554 |
MOD_GSK3_1 | 52 | 59 | PF00069 | 0.805 |
MOD_GSK3_1 | 81 | 88 | PF00069 | 0.783 |
MOD_N-GLC_1 | 162 | 167 | PF02516 | 0.392 |
MOD_NEK2_1 | 298 | 303 | PF00069 | 0.524 |
MOD_NEK2_1 | 54 | 59 | PF00069 | 0.785 |
MOD_PIKK_1 | 102 | 108 | PF00454 | 0.708 |
MOD_PIKK_1 | 30 | 36 | PF00454 | 0.764 |
MOD_PKA_2 | 302 | 308 | PF00069 | 0.584 |
MOD_Plk_1 | 102 | 108 | PF00069 | 0.681 |
MOD_Plk_4 | 182 | 188 | PF00069 | 0.624 |
MOD_Plk_4 | 198 | 204 | PF00069 | 0.547 |
MOD_ProDKin_1 | 162 | 168 | PF00069 | 0.548 |
MOD_ProDKin_1 | 341 | 347 | PF00069 | 0.557 |
MOD_SUMO_for_1 | 212 | 215 | PF00179 | 0.624 |
MOD_SUMO_for_1 | 95 | 98 | PF00179 | 0.852 |
MOD_SUMO_rev_2 | 117 | 124 | PF00179 | 0.671 |
MOD_SUMO_rev_2 | 13 | 22 | PF00179 | 0.759 |
MOD_SUMO_rev_2 | 206 | 214 | PF00179 | 0.569 |
MOD_SUMO_rev_2 | 58 | 66 | PF00179 | 0.834 |
MOD_SUMO_rev_2 | 68 | 73 | PF00179 | 0.806 |
TRG_DiLeu_BaLyEn_6 | 72 | 77 | PF01217 | 0.608 |
TRG_ENDOCYTIC_2 | 205 | 208 | PF00928 | 0.524 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P3S7 | Leptomonas seymouri | 72% | 100% |
A0A1X0NR97 | Trypanosomatidae | 54% | 73% |
A0A3Q8IDB8 | Leishmania donovani | 97% | 100% |
A0A3R7L212 | Trypanosoma rangeli | 50% | 77% |
A4HGV2 | Leishmania braziliensis | 87% | 100% |
A4I3Y2 | Leishmania infantum | 97% | 100% |
D0A951 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 43% | 79% |
E9B072 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |